Genome & Company Market Cap

Genome & Company has a market cap or net worth of 220.87 billion as of March 9, 2026. Its market cap has increased by 158.63% in one year.

Market Cap

220.87B

Enterprise Value

210.00B

Revenue

25.95B

Ranking

n/a

PE Ratio

n/a

Stock Price

7,030.00

Market Cap Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 220.87B, an increase of 207.29%. That is a compound annual growth rate of 16.86%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	220.87B	-7.35%
Dec 30, 2025	238.38B	179.77%
Dec 30, 2024	85.21B	-51.64%
Dec 28, 2023	176.21B	-28.34%
Dec 29, 2022	245.90B	-47.55%
Dec 30, 2021	468.83B	-55.28%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Prestige Biologics	202.16B
TiumBio	197.44B
ISU Abxis	196.27B
Ensol Biosciences	191.69B
Kangstem Biotech	189.05B
ABION	259.94B
QuadMedicine	186.24B
Bio Solution	284.51B

Market Cap Rankings